Authors
Loading...
Experimental study reveals gut microbiota regulation of plasma cholesterol and hepatic synthesis in mice, highlighting microbial targets for treating dyslipidemia.
Roy et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: